期刊文献+

几种隐性遗传性单基因皮肤病基因治疗研究现状 被引量:1

下载PDF
导出
摘要 隐性遗传性单基因皮肤病是进行基因治疗研究的理想候选疾病 ,目前这一领域的许多研究进展迅速 ,但传递基因的表达调控和机体的免疫应答仍是研究的难点。
出处 《国外医学(皮肤性病学分册)》 2002年第6期340-343,共4页 Foreign Medical Sciences(Section of Dermatology and Venereology)
  • 相关文献

参考文献28

  • 1Lin MT, Pulkkinen L, Uitto J. Cutaneous gene therapy. Principles and prospects. Dermatol Clin, 2000, 18( 1 ) :177-188.
  • 2Greenhalgh DA, Rothnagel JA, Roop DR. Epidermis: an attractive target tissue for gene therapy. J Invest Dermatol, 1994, 103 ( 5 Suppl): S63- S69.
  • 3Lin MT, Pulkkinen L, Uitto J, et al. The gene gun: current applications in cutaneous gene therapy. Int J Dermato, 2000, 39 (3) :161-170.
  • 4Huber M, Limat A, Wagner E, et al. Efficient in vitro transfection of human keratinocytes with an adenovirus-enhanced receptor-mediated system. J Invest Dermatol, 2000, 114 (4) :661-666.
  • 5Borradori L, Sonnenberg A. Structure and function of hemidesmosomes: more than simple adhesion complexes. J Invest Dermatol,1999, 112(4) :411-418.
  • 6Burgeson RE, Chiquet M, Deutzmann R, et al. A new nomenclature for the laminins. Matrix Biol, 1994, 14(3) :209-211.
  • 7Pulkkinen L, Uitto J. Hemidesmosomal variants of epidermolysis bullosa. Mutations in the alpha6beta4 integrin and the 180-kD bullous pemphigoid antigen/type ⅩⅦ collagen genes. Exp Dermatol, 1998, 7(2-3) :46-64.
  • 8Gagnoux-Palacios L, Vailly J, Durand-Clement M, et al. Functional Re-expression of laminin-5 in laminin-gamma2-deficient human keratinocytes modifies cell morphology, motility, and adhesion. J Biol Chem, 1996, 271 (31): 18437-18444.
  • 9Gagnoux-Palacios L, Gache Y, Ortonne JP, et al. Hemidesmosome assembly assessed by expression of a wild-type integrin beta 4 cDNA in junctional epidermolysis bullosa keratinocytes. Lab Invest, 1997, 77(5) :459-468.
  • 10Robbins PB, Lin Q, Goodnough JB, et al. In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa. Proc Natl Acad Sci U S A, 2001,98(9) :5193-5198.

同被引文献21

  • 1McKenna KE, Walsh MY, Bingham EA.Epidermolysis bullosa in Northern Ireland.Br J Dermatol, 1992, 127: 318-321.
  • 2Horn HM, Priestley GC, Eady RA, et al.The prevalence of epidermolysis bullosa in Scotland. Br J Dermatol, 1997, 136: 560-564.
  • 3Fine JD, Eady RA, Bauer EA, et al. Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa.J Am Acad Dermatol, 2000, 42: 1051-1066.
  • 4赵辨,靳培英,葛以信,等主编.皮肤病彩色图谱.江苏:江苏科学技术出版社,1995.206.
  • 5Mallory SB, Leal-Khouri S. An Illustrated Dictionary of Dermatologic Syndromes. New York: Parthenon Pub, 1994. 70-74.
  • 6Weedon D, Strutton G. Skin Pathology. 2nd ed. Edinburgh: Churchill Livingstone, 2002.138-148.
  • 7Wojnarowska F, Eady RA, Burge SM. Bullous eruptions. In: Champion RH, et al.eds. Textbook of Dermatology. Vol 3. 6th ed. Oxford:Blackwell Science Ltd, 1998.1817-1844.
  • 8Retief CR, Malkinson FD, Pearson RW.Two familial cases of epidermolysis bullosa simplex successfully treated with tetracycline. Arch Dermatol, 1999, 135: 997-998.
  • 9Veien NK, Buus SK. Treatment of epidermolysis bullosa simplex (EBS) with tetracycline. Arch Dermatol, 2000, 136: 424-425.
  • 10Anthony du Vivier. Atlas of Clinical Dermatology. 3rd ed. London: Churchill Livingstone, 2002. 462-469.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部